calpain and 2-5-dihydrophenylalanine

calpain has been researched along with 2-5-dihydrophenylalanine* in 1 studies

Other Studies

1 other study(ies) available for calpain and 2-5-dihydrophenylalanine

ArticleYear
L-2,5-dihydrophenylalanine, an inducer of cathepsin-dependent apoptosis in human promyelocytic leukemia cells (HL-60).
    The Journal of antibiotics, 2001, Volume: 54, Issue:10

    L-2,5-Dihydrophenylalanine (DHPA), a phenylalanine analogue, induced apoptosis in human promyelocytic leukemia cells (HL-60). This apoptosis was demonstrated by morphological changes of the cells, such as fragmentation of nuclei and chromatin condensation, and by some evidence found in biochemical analysis, such as DNA ladder and activation of caspase 3. The DHPA-induced apoptosis was prevented by a pan-caspase inhibitor, Z-VAD-fmk, and a cysteine protease inhibitor, E-64d, which inhibits calpains and cathepsin B and L. A calpain inhibitor, Z-LL-H, did not affect this apoptosis. A cathepsin B specific inhibitor, CA074-Me, prevented only chromatin condensation. However, E-64d and a cathepsin L specific inhibitor, Z-FY(t-Bu)-dmk, protected the cells from both chromatin condensation and oligonucleosomal DNA fragmentation. As proceeding to the apoptotic process, the activities of both cathepsin B and L increased gradually. These results indicated that DHPA was an inducer of cathepsin-dependent apoptosis in HL-60 cells.

    Topics: Apoptosis; Calpain; Caspase 3; Caspase Inhibitors; Caspases; Cathepsins; Cell Division; Cell Nucleus; Chromatin; Cyclohexenes; Cysteine Proteinase Inhibitors; DNA Fragmentation; Fluorescent Dyes; HL-60 Cells; Humans; Nucleosomes; Phenylalanine; Protease Inhibitors

2001